Pages that link to "Q33999537"

The following pages link to Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease (Q33999537):

Displaying 50 items.

• Variant of TREM2 Associated with the Risk of Alzheimer's Disease (Q22250874) (← links)
• Genetics ignite focus on microglial inflammation in Alzheimer's disease (Q26781865) (← links)
• Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss (Q27008993) (← links)
• Functional involvement of γ-secretase in signaling of the triggering receptor expressed on myeloid cells-2 (TREM2). (Q27303397) (← links)
• Targeting neuroinflammation in Alzheimer's disease (Q28078474) (← links)
• Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β. (Q33359453) (← links)
• Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. (Q33727947) (← links)
• Harnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury model (Q33919488) (← links)
• Differentiation of mouse bone marrow derived stem cells toward microglia-like cells. (Q33997746) (← links)
• The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk. (Q34303825) (← links)
• Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease (Q34499359) (← links)
• Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke (Q34542247) (← links)
• Frontobasal gray matter loss is associated with the TREM2 p.R47H variant (Q34620183) (← links)
• A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model (Q34746889) (← links)
• Development of a culture system to induce microglia-like cells from haematopoietic cells (Q34805641) (← links)
• The evolving biology of microglia in Alzheimer's disease. (Q35064995) (← links)
• ProphNet: a generic prioritization method through propagation of information (Q35101468) (← links)
• Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia (Q35555134) (← links)
• TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices (Q35593790) (← links)
• RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment. (Q35662879) (← links)
• A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology (Q35702861) (← links)
• The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia (Q35706990) (← links)
• TREM2 regulates microglial cell activation in response to demyelination in vivo (Q36341689) (← links)
• Microglial malfunction: the third rail in the development of Alzheimer's disease (Q36348184) (← links)
• C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity (Q36508752) (← links)
• The triggering receptor expressed on myeloid cells 2: "TREM-ming" the inflammatory component associated with Alzheimer's disease (Q36711780) (← links)
• Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta (Q36996975) (← links)
• Transcriptome Analysis on Monocytes from Patients with Neovascular Age-Related Macular Degeneration (Q37061531) (← links)
• Expression of the phagocytosis-essential protein TREM2 is down-regulated by an aluminum-induced miRNA-34a in a murine microglial cell line (Q37232651) (← links)
• Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease. (Q37592180) (← links)
• Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx. (Q38012092) (← links)
• TREM2 in Alzheimer's disease (Q38081367) (← links)
• Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease (Q38108433) (← links)
• The innate immune system in Alzheimer's disease. (Q38162221) (← links)
• Innate immune activation in neurodegenerative disease (Q38223011) (← links)
• TYROBP in Alzheimer's disease (Q38232823) (← links)
• The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders. (Q38348923) (← links)
• Innate immunity in Alzheimer's disease (Q38358574) (← links)
• TREM2 in Neurodegenerative Diseases (Q38646212) (← links)
• The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases (Q38676359) (← links)
• A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells (Q38704022) (← links)
• The Alzheimer's disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway (Q38711499) (← links)
• TREM2 variants: new keys to decipher Alzheimer disease pathogenesis (Q38748724) (← links)
• Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease (Q39243339) (← links)
• Differential detection of impact site versus rotational site injury by magnetic resonance imaging and microglial morphology in an unrestrained mild closed head injury model (Q41285877) (← links)
• Recent Advances from the Bench Toward the Bedside in Alzheimer's Disease (Q41615921) (← links)
• CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection (Q41775007) (← links)
• Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis (Q42177260) (← links)
• Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage (Q42244965) (← links)
• LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent (Q42482604) (← links)